Work

Phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with temozolomide (TMZ) in patients with malignant gliomas (NABTC 04–03)

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.2039

Authors: P. Y. Wen, V. Puduvalli, J. Kuhn, J. Reid, T. Cloughesy, W. A. Yung, S. M. Chang, H. I. Robbins, R. McGovern, M. Ames, M. D. Prados

Institutions: Mayo Clinic, University of Wisconsin–Madison, University of California, Los Angeles, University of California, San Francisco, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Dana-Farber Cancer Institute

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2609068367

Cites:

Cited by: 6

Related to: 10